« Back Journal of Dermatological Science

Article in Press

Oral administration of Yokukansan inhibits the development of atopic dermatitis-like lesions in isolated NC/Nga mice

  • Ju Jiang

      Affiliations

    • Atopy (Allergy) Research Center, Juntendo University School of Medicine, 2-1-1 Hongo, Bunkyo-ku, 113-8421 Tokyo, Japan
    • Department of Dermatology, Juntendo University School of Medicine, 2-1-1 Hongo, Bunkyo-ku, 113-8421 Tokyo, Japan
    • Fuzhou Dermatosis Prevention and Control Hospital, 243 Xi Hong Lu, Gu Lou Qu, 350025 FuZhou, China
    • Corresponding Author InformationCorresponding author at: Atopy (Allergy) Research Center, Juntendo University School of Medicine, 2-1-1 Hongo, Bunkyo-ku, 113-8421 Tokyo, Japan. Tel.: +81 3 5802 1089; fax: +81 3 3813 9443.
    • ,
  • Takuji Yamaguchi

      Affiliations

    • Department of Dermatology, Juntendo University School of Medicine, 2-1-1 Hongo, Bunkyo-ku, 113-8421 Tokyo, Japan
    • Tsumura Research Laboratories, Tsumura & Co, 3586 Yoshiwara, Ami-machi, Inashiki-gun, 300-1192 Ibaraki, Japan
    • ,
  • Naoko Funakushi

      Affiliations

    • Department of Dermatology, Juntendo University School of Medicine, 2-1-1 Hongo, Bunkyo-ku, 113-8421 Tokyo, Japan
    • ,
  • Takatoshi Kuhara

      Affiliations

    • Atopy (Allergy) Research Center, Juntendo University School of Medicine, 2-1-1 Hongo, Bunkyo-ku, 113-8421 Tokyo, Japan
    • ,
  • Ping-shen Fan

      Affiliations

    • Department of Dermatology, Juntendo University School of Medicine, 2-1-1 Hongo, Bunkyo-ku, 113-8421 Tokyo, Japan
    • ,
  • Rie Ueki

      Affiliations

    • Dermatology Unit, Juntendo Tokyo Geriatric Medical Center, 3-3-20 Shinsuna, Koto-ku, 136-0075 Tokyo, Japan
    • ,
  • Hajime Suto

      Affiliations

    • Atopy (Allergy) Research Center, Juntendo University School of Medicine, 2-1-1 Hongo, Bunkyo-ku, 113-8421 Tokyo, Japan
    • Department of Dermatology, Juntendo University School of Medicine, 2-1-1 Hongo, Bunkyo-ku, 113-8421 Tokyo, Japan
    • ,
  • Yoshio Kase

      Affiliations

    • Tsumura Research Laboratories, Tsumura & Co, 3586 Yoshiwara, Ami-machi, Inashiki-gun, 300-1192 Ibaraki, Japan
    • ,
  • Shigaku Ikeda

      Affiliations

    • Atopy (Allergy) Research Center, Juntendo University School of Medicine, 2-1-1 Hongo, Bunkyo-ku, 113-8421 Tokyo, Japan
    • Department of Dermatology, Juntendo University School of Medicine, 2-1-1 Hongo, Bunkyo-ku, 113-8421 Tokyo, Japan
    • ,
  • Hideoki Ogawa

      Affiliations

    • Atopy (Allergy) Research Center, Juntendo University School of Medicine, 2-1-1 Hongo, Bunkyo-ku, 113-8421 Tokyo, Japan
    • Department of Dermatology, Juntendo University School of Medicine, 2-1-1 Hongo, Bunkyo-ku, 113-8421 Tokyo, Japan

Received 11 February 2009 ,Revised 1 July 2009 ,Accepted 3 July 2009. Published online 12 July 2010 Corrected Proof

References 

  1. Hashiro M, Okumura M. Anxiety, depression and psychosomatic symptoms in patients with atopic dermatitis: comparison with normal controls and among groups of different degrees of severity. J Dermatol Sci. 1997;14:63–67
  2. Kimyai-Asadi A, Usman A. The role of psychological stress in skin disease. J Cutan Med Surg. 2001;5:140–145
  3. Seiffert K, Hilbert E, Schaechinger H, Zouboulis CC, Deter HC. Psychophysiological reactivity under mental stress in atopic dermatitis. Dermatology. 2005;210:286–293
  4. Hashizume H, Horibe T, Ohshima A, Ito T, Yagi H, Takigawa M. Anxiety accelerates T-helper 2-tilted immune responses in patients with atopic dermatitis. Br J Dermatol. 2005;152:1161–1164
  5. Chida Y, Steptoe A, Hirakawa N, Sudo N, Kubo C. The effects of psychological intervention on atopic dermatitis. Int Arch Allergy Immunol. 2007;144:1–9
  6. Linnet J, Jemec GB. An assessment of anxiety and dermatology life quality in patients with atopic dermatitis. Br J Dermatol. 1999;140:268–272
  7. Koblenzer CS. Itching and the atopic skin. J Allergy Clin Immunol. 1999;104:S109–S113
  8. Jiang J, Kuhara T, Ueki R, Zheng Y, Suto H, Ikeda S, et al. Inhibitory effects of paroxetine on the development of atopic dermatitis-like lesions in NC/Nga mice. J Dermatol Sci. 2007;47:244–247
  9. Terasawa K. KAMPO Japanese-Oriental Medicine: Insights from Clinical Cases. Tokyo: Standard McIntyre; 1993;
  10. Koshikawa N, Imai T, Takahashi I, Yamauchi M, Sawada S, Kansaku K. Effects of Hochu-eki-to, Yoku-kan-san and Saiko-ka-ryukotsu-borei-to on behavioral despair and acetic acid-induced writhing in mice. Methods Find Exp Clin Pharmacol. 1998;20:47–51
  11. Tahara E, Wu WJ1, Satoh T, Yamada T, Kurosaki Nagai H, Nunome S, et al. Psychosocial stress enhances IgE-mediated triphasic cutaneous reaction in mice: antagonism by Yokukan-san (a Kampo medicine) and diazepam. Allergol Int. 2001;50:211–222
  12. Matsuda H, Watanabe N, Geba GP, Sperl J, Tsudzuki M, Hiroi J, et al. Development of atopic dermatitis-like skin lesion with IgE hyperproduction in NC/Nga mice. Int Immunol. 1997;9:461–466
  13. Suto H, Matsuda H, Mitsuishi K, Hira K, Uchida T, Unno T, et al. NC/Nga mice: a mouse model for atopic dermatitis. Int Arch Allergy Immunol. 1999;120:70–75
  14. Yamaguchi T, Maekawa T, Nishikawa Y, Nojima H, Kaneko M, Kawakita T, et al. Characterization of itch-associated responses of NC mice with mite-induced chronic dermatitis. J Dermatol Sci. 2001;25:20–28
  15. Kim JW, Kirkpatrick B. Social isolation in animal models of relevance to neuropsychiatric disorders. Biol Psychiatry. 1996;40:918–922
  16. Bowers SL, Bilbo SD, Dhabhar FS, Nelson RJ. Stressor-specific alterations in corticosterone and immune responses in mice. Brain Behav Immun. 2008;22:105–113
  17. Ojima K, Matsumoto K, Tohda M, Watanabe H. Hyperactivity of central noradrenergic and CRF systems is involved in social isolation-induced decrease in pentobarbital sleep. Brain Res. 1995;684:87–94
  18. Pashko S, Deyurck KH, Vogel WH. Use of the catheterized rat in studies on social interaction and plasma catecholamine. Pharmacol Biochem Behav. 1980;13:471–473
  19. Nguyen TT, Matsumoto K, Yamasaki K, Watanabe H. Majonoside-R2 reverses social isolation stress-induced decrease in pentobarbital sleep in mice: Possible involvement of neuroactive steroids. Life Sci. 1997;61:395–402
  20. Welch JM, Lu J, Rodriguiz RM, Trotta NC, Peca J, Ding JD, et al. Cortico-striatal synaptic defects and OCD-like behaviours in Sapap3-mutant mice. Nature. 2007;23:894–900
  21. Kondo K, Nagami T, Teramoto S. Differences in haematopoietic death among inbred strains of mice. In:  Bond SV,  Sugahara T editor. Comparative cellular and species radiosensitivity. Tokyo: Igakushoin; 1964;p. 20–29
  22. Ständer S, Steinhoff M, Schmelz M, Weisshaar E, Metze D, Luger T. Neurophysiology of pruritus: cutaneous elicitation of itch. Arch Dermatol. 2003;139:1463–1470
  23. Elenkov IJ. Neurohormonal-cytokine interactions: implications for inflammation, common human diseases and well-being. Neurochem Int. 2008;52:40–51
  24. Paus R, Schmelz M, Bíró T, Steinhoff M. Frontiers in pruritus research: scratching the brain for more effective itch therapy. J Clin Invest. 2006;116:1174–1186
  25. Arck P, Paus R. From the brain-skin connection: the neuroendocrine-immune misalliance of stress and itch. Neuroimmunomodulation. 2006;13:347–356
  26. Amano H, Negishi I, Akiyama H, Ishikawa O. Psychological stress can trigger atopic dermatitis in NC/Nga mice: an inhibitory effect of corticotropin-releasing factor. Neuropsychopharmacology. 2008;33:566–573
  27. Singh LK, Boucher W, Pang X, Letourneau R, Seretakis D, Green M, et al. Potent mast cell degranulation and vascular permeability triggered by urocortin through activation of corticotropin-releasing hormone receptors. J Pharmacol Exp Ther. 1999;288:1349–1356
  28. Slominski A, Wortsman J, Luger T, Paus R, Solomon S. Corticotropin releasing hormone and proopiomelanocortin involvement in the cutaneous response to stress. Physiol Rev. 2000;80:979–1020
  29. Theoharides TC, Singh LK, Boucher W, Pang X, Letourneau R, Webster E, et al. Corticotropin-releasing hormone induces skin mast cell degranulation and increased vascular permeability, a possible explanation for its proinflammatory effects. Endocrinology. 1998;139:403–413
  30. Cassano WJ, D’mello AP. Acute stress-induced facilitation of the hypothalamic–pituitary–adrenal axis: evidence for the roles of stressor duration and serotonin. Neuroendocrinology. 2001;74:167–177
  31. Miyata K, Ito H, Fukudo S. Involvement of the 5-HT3 receptor in CRH-induce defecation in rats. Am J Physiol. 1998;274:827–831
  32. Tateno M, Ukai W, Ono T, Saito S, Hashimoto E, Saito T. Neuroprotective effects of Yi-Gan San against beta amyloid-induced cytotoxicity on rat cortical neurons. Prog Neuropsychopharmacol Biol Psychiatry. 2008;32:1704–1707
  33. Egashira N, Iwasaki K, Ishibashi A, Hayakawa K, Okuno R, Abe M, et al. Repeated administration of Yokukansan inhibits DOI-induced head-twitch response and decreases expression of 5-hydroxytryptamine (5-HT)2A receptors in the prefrontal cortex. Prog Neuropsychopharmacol Biol Psychiatry. 2008;32:1516–1520

PII: S0923-1811(09)00199-6

doi: 10.1016/j.jdermsci.2009.07.003

« Back Journal of Dermatological Science

Article in Press

Article Tools

* Image Usage & Resolution